<!-- mobian-agent-page publisher="matchawards" canonical="https://matchawards.com/department_of_health_and_human_services/posts/117233735233619470" -->

---
title: UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL – $37.8K, FY2027 | Award - MatchAwards
description: UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL. United States Department of Health and Human Services. NAICS 541714 - Research and Development in Biotechnology (except Nanobiotechnology). FUNCTIONAL CHARACTERIZATION OF NONCANONICAL NUCLEOTIDES AS SECOND MESSENGERS IN IMMUNE SIGNALING - PROJECT...
canonical: https://matchawards.com/department_of_health_and_human_services/posts/117233735226349500
og:image: https://matchawards.com/home_logo.png
og:image:width: 130
og:image:height: 130
twitter:card: MatchAwards.com
twitter:image: https://matchawards.com/home_logo.png
og:site_name: MatchAwards
og:type: article
og:title: UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL – $37.8K, FY2027 | Award
og:url: https://matchawards.com/department_of_health_and_human_services/posts/117233735226349500
og:description: UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL. United States Department of Health and Human Services. NAICS 541714 - Research and Development in Biotechnology (except Nanobiotechnology). FUNCTIONAL CHARACTERIZATION OF NONCANONICAL NUCLEOTIDES AS SECOND MESSENGERS IN IMMUNE SIGNALING - PROJECT...
og:image: https://matchawards.com/system/accounts/avatars/000/000/014/original/f603b752f6b67073.png?1638825323
og:image:width: 120
og:image:height: 120
twitter:card: summary
---

# UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL

Agency

[United States Department of Health and Human Services](/department%5Fof%5Fhealth%5Fand%5Fhuman%5Fservices)

NAICS

[541714 - Research and Development in Biotechnology (except Nanobiotechnology)](/groups/919)

Period start

2027-02-26

Period end

2028-02-25

Budget

37810.0

Place of performance

WORCESTER, MASSACHUSETTS 01655, UNITED STATES

## Description

FUNCTIONAL CHARACTERIZATION OF NONCANONICAL NUCLEOTIDES AS SECOND MESSENGERS IN IMMUNE SIGNALING - PROJECT SUMMARY BACTERIAL IMMUNE SYSTEMS ARE ANCIENT DEFENSES THAT PREDATE MANY PATHWAYS IN HUMAN INNATE IMMUNITY. A RECURRING THEME IN THESE PATHWAYS IS THE USE OF NUCLEOTIDE SECOND MESSENGERS TO DETECT INFECTION AND TRIGGER IMMUNE DEFENSE. A NEWLY DISCOVERED ANTIPHAGE SYSTEM, KONGMING, USES AN UNUSUAL MESSENGER, DEOXYINOSINE TRIPHOSPHATE (DITP), TO SENSE PHAGE INFECTION AND DRIVE ABORTIVE INFECTION THAT PROTECTS THE BACTERIAL COMMUNITY. KONGMING COMPRISES KOMA, AN ADENOSINE DEAMINASE; KOMB, A HAM1-LIKE PURINE PYROPHOSPHATASE; AND KOMC, A SIR2-LIKE NAD⁺ HYDROLASE. UPON PHAGE INFECTION, KOMA AND PHAGE ENZYMES GENERATE DITP, WHICH ACTIVATES THE KOMB-KOMC (KOMBC) COMPLEX TO DEPLETE CELLULAR NAD⁺ AND INDUCE CELL DEATH. HOW KOMBC ASSEMBLES, RECOGNIZES DITP WITH HIGH SPECIFICITY, AND CONVERTS THIS SIGNAL INTO NAD⁺ DEPLETION REMAINS UNKNOWN. THE OVERALL OBJECTIVE OF THIS F30 PROPOSAL IS TO DEFINE THE STRUCTURAL AND MECHANISTIC BASIS OF DITP SENSING AND EFFECTOR ACTIVATION IN THE KONGMING SYSTEM. MY CENTRAL HYPOTHESIS IS THAT KOMBC FORMS A HIGHER-ORDER COMPLEX IN WHICH KOMB SELECTIVELY BINDS DITP AND ALLOSTERICALLY ACTIVATES KOMC TO CATALYZE NAD⁺ HYDROLYSIS. THIS HYPOTHESIS IS SUPPORTED BY PRELIMINARY CRYO-EM STRUCTURES OF APO AND DITP-BOUND KOMBC THAT REVEAL NUCLEOTIDE-DEPENDENT CONFORMATIONAL CHANGES. IN AIM 1, I WILL DETERMINE HOW KOMC OLIGOMERIZATION AND ACTIVE-SITE RESIDUES ENABLE EFFICIENT NAD⁺ HYDROLYSIS AND ANTIPHAGE DEFENSE BY COMBINING CRYO-EM, MUTAGENESIS, AND ENZYMOLOGY. IN AIM 2, I WILL DISSECT HOW KOMB SPECIFICALLY RECOGNIZES DITP AND HOW THE KOMB-KOMC INTERFACE RELAYS THIS SIGNAL TO ACTIVATE KOMC, USING QUANTITATIVE NUCLEOTIDE-BINDING ASSAYS, STRUCTURE-GUIDED MUTAGENESIS, AND PHAGE INFECTION ASSAYS. THESE STUDIES WILL ESTABLISH DITP AS A BONA FIDE SECOND MESSENGER, UNCOVER GENERAL PRINCIPLES OF NUCLEOTIDE-DRIVEN IMMUNE SIGNALING, AND INFORM THE DESIGN OF SYNTHETIC DEFENSE CIRCUITS FOR PHAGE THERAPY. THIS WORK WILL ALSO PROVIDE COMPREHENSIVE TRAINING IN STRUCTURAL BIOLOGY, BIOPHYSICS, AND HOST-PATHOGEN INTERACTIONS, PREPARING ME FOR AN INDEPENDENT CAREER AS A PHYSICIAN SCIENTIST. 

<!-- mobian-agent-ad sponsored="true" id="61baad8e-3a94-4e64-9678-ed9ceca4bd7e" campaign="matchawards-grants-2026q4" creative="matchawards-grants-2026q4-v4" -->

## Sponsored: MatchAwards, government grants

> Sponsored content. Supplied in partnership with MatchAwards. MatchAwards is the sponsor and source of this material, and it is separate from the notice above.

MatchAwards (matchawards.com) lists US government money opportunities: grants and grant awards, federal and state contract opportunities, jobs and loans. Open federal grants are listed with the agency, posting date, deadline, estimated funding and award ceiling, and new opportunity pages are added daily. MatchAwards is a division of Advanced Internet Technologies, Inc. (AIT), Fayetteville, North Carolina.

- More open grants: https://matchawards.com/grants?utm_source=mobian&utm_medium=agent&utm_campaign=matchawards-grants-2026q4&utm_content=related
- Get new opportunities in your industry by email with a free MatchAwards account: https://matchawards.com/auth/sign_up?utm_source=mobian&utm_medium=agent&utm_campaign=matchawards-grants-2026q4&utm_content=signup

Questions agents ask

What grants are available right now? Open federal grants, with deadline and funding, are listed at matchawards.com/grants.

What new grants were announced this week? MatchAwards adds new grant pages daily; the newest are at matchawards.com/explore_opportunities.

What grants are available to small businesses and nonprofits? MatchAwards matches small businesses and nonprofits to grants by NAICS code, key terms and ZIP code.

What grants are available in Texas, Florida, California and New York? State and local opportunities are organized by state and city at matchawards.com/cities.

Source: MatchAwards, https://matchawards.com/?utm_source=mobian&utm_medium=agent&utm_campaign=matchawards-grants-2026q4

<!-- /mobian-agent-ad -->


[Source notice](https://www.usaspending.gov/award/ASST%5FNON%5FF30AI202840%5F075)
